Allspring Global Investments Holdings LLC Trims Position in Prestige Consumer Healthcare Inc. $PBH

Allspring Global Investments Holdings LLC lessened its holdings in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) by 5.8% during the second quarter, HoldingsChannel reports. The firm owned 1,521,999 shares of the company’s stock after selling 93,997 shares during the quarter. Allspring Global Investments Holdings LLC’s holdings in Prestige Consumer Healthcare were worth $122,247,000 at the end of the most recent quarter.

A number of other large investors also recently made changes to their positions in the business. GAMMA Investing LLC raised its position in shares of Prestige Consumer Healthcare by 35.9% in the 1st quarter. GAMMA Investing LLC now owns 1,879 shares of the company’s stock worth $162,000 after buying an additional 496 shares during the period. Opal Wealth Advisors LLC acquired a new stake in Prestige Consumer Healthcare in the 1st quarter valued at $38,000. QRG Capital Management Inc. increased its holdings in Prestige Consumer Healthcare by 8.6% in the 1st quarter. QRG Capital Management Inc. now owns 5,971 shares of the company’s stock valued at $513,000 after purchasing an additional 475 shares in the last quarter. Avior Wealth Management LLC increased its holdings in Prestige Consumer Healthcare by 38.2% in the 1st quarter. Avior Wealth Management LLC now owns 11,824 shares of the company’s stock valued at $1,017,000 after purchasing an additional 3,270 shares in the last quarter. Finally, Advisor Resource Council acquired a new stake in shares of Prestige Consumer Healthcare during the first quarter valued at about $2,232,000. Hedge funds and other institutional investors own 99.95% of the company’s stock.

Prestige Consumer Healthcare Stock Performance

PBH opened at $61.83 on Tuesday. Prestige Consumer Healthcare Inc. has a twelve month low of $60.15 and a twelve month high of $90.04. The stock has a market cap of $3.04 billion, a PE ratio of 14.51, a price-to-earnings-growth ratio of 1.93 and a beta of 0.44. The business’s 50 day moving average is $65.02 and its 200-day moving average is $75.91. The company has a current ratio of 4.38, a quick ratio of 2.99 and a debt-to-equity ratio of 0.55.

Prestige Consumer Healthcare (NYSE:PBH) last announced its earnings results on Thursday, August 7th. The company reported $0.95 EPS for the quarter, missing the consensus estimate of $1.01 by ($0.06). The firm had revenue of $249.53 million for the quarter, compared to the consensus estimate of $260.71 million. Prestige Consumer Healthcare had a return on equity of 12.69% and a net margin of 19.02%.Prestige Consumer Healthcare’s revenue for the quarter was down 6.6% on a year-over-year basis. During the same period in the previous year, the firm earned $0.90 EPS. Prestige Consumer Healthcare has set its FY 2026 guidance at 4.500-4.580 EPS. On average, analysts predict that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current year.

Wall Street Analysts Forecast Growth

PBH has been the subject of several recent analyst reports. Canaccord Genuity Group lowered their target price on Prestige Consumer Healthcare from $105.00 to $100.00 and set a “buy” rating for the company in a research note on Friday, August 8th. Wall Street Zen downgraded Prestige Consumer Healthcare from a “buy” rating to a “hold” rating in a research note on Saturday, August 9th. Sidoti upgraded Prestige Consumer Healthcare from a “neutral” rating to a “buy” rating and set a $80.00 target price for the company in a research note on Wednesday, September 24th. Zacks Research downgraded Prestige Consumer Healthcare from a “hold” rating to a “strong sell” rating in a research note on Thursday, September 4th. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Prestige Consumer Healthcare in a research note on Wednesday, October 8th. Four analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $94.80.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.